Binaural Sound for Remimazolam Maintenance

Last updated: August 7, 2024
Sponsor: Gangnam Severance Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Uterine Fibroids

Desmoid Tumors

Anesthesia

Treatment

Binaural sound

Clinical Study ID

NCT06497283
3-2024-0171
  • Ages > 20
  • All Genders

Study Summary

It is important to decrease the remifentanil dose for general anesthesia maintenance when using remimazolam. We will evaluate the effect of binaural sound on general anesthesia maintenance with remimazolam infusion.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patients scheduled for general anesthesia

  2. Patients aged 20-60

  3. Patients with American Society of Anesthesiologist physical status classification 1-2

  4. Patients with ideal body weight 50-80 kg

Exclusion

Exclusion Criteria:

  1. Patients with hearing disability

  2. Patients using opioids or sedatives in 1 week

  3. Patients who are dependent for alcoholics or drugs

  4. Patients with hypersensitivities to remimazolam or remifentanil

  5. Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia

  6. Patients with liver failure

Study Design

Total Participants: 72
Treatment Group(s): 1
Primary Treatment: Binaural sound
Phase:
Study Start date:
July 12, 2024
Estimated Completion Date:
February 28, 2025

Connect with a study center

  • Gangnam Severance Hospital

    Seoul,
    Korea, Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.